Espumisan

Quick links to important sections

Espumisan

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Espumisan

Property Description
Active ingredient Simethicone (Simeticone, INN)
Forms Oral Capsules, Oral Drops, Chewable Tablets
Pharmacological Class Gastrointestinal Agent, Antiflatulent
Common Use Relief of gas-related bloating and pressure
Origin Synthetic silicone compound

What Type of Medicine is Espumisan? (Definition and Classification)

Espumisan, a product of Berlin Chemie AG, is a widely accessible Over-the-Counter (OTC) pharmaceutical classified as a Gastrointestinal Agent, specifically an Antiflatulent and Antifoaming Agent. This classification defines the medication's primary role: providing symptomatic relief from gastrointestinal complaints related to the excessive accumulation of gas, such as uncomfortable bloating and fullness. This confirms the medicine helps ease common gas symptoms by physically targeting the foam buildup responsible for the feeling of pressure in the digestive tract.


Simethicone: Composition, Origin, and Forms

The efficacy of Espumisan relies entirely on its single active ingredient, Simethicone (Simeticone, INN), which is a silicone-based antifoaming agent. Simethicone is a synthetic substance, chemically defined as a stable mixture of polydimethylsiloxane and silica gel. As a dedicated single-ingredient product, Espumisan is manufactured for oral administration and is distinguished by its range of dosage forms, including Oral Capsules (softgel capsules), Chewable Tablets, and stabilized liquid Oral Drops (emulsion or suspension), allowing tailored use across various patient groups.


How Does Espumisan Provide Relief? (General Purpose and Mechanism)

Espumisan provides relief through a purely physical action confined to the gut lumen, functioning as a specialized surfactant to manage entrapped gas. The high-level mechanism involves the compound drastically lowering the surface tension of the numerous small, foamy gas bubbles trapped within the digestive system. This physical process causes the bubbles to collapse and consolidate into larger, free gas pockets. This principle is utilized to manage symptoms by reducing gas presence in the gastrointestinal tract. This indicates that the medication works by directly dissolving the foam bubbles, thereby making the gas easier to pass naturally. Additionally, this foam-clearing action is leveraged in clinical settings to improve visualization by eliminating gas shadows that obscure internal structures during diagnostic tests, such as ultrasound examinations.

Regulatory References

  1. Simethicone - StatPearls - NCBI Bookshelf
  2. Simethicone: MedlinePlus Drug Information

What side effects are possible with Espumisan?

Possible Side Effects and Safety Information

Simethicone, the active component in Espumisan, is not absorbed by the body, limiting its safety profile to local effects and allergic reactions. The majority of reported adverse events are sourced from post-marketing surveillance, where their exact frequency cannot be reliably estimated, a classification often described in regulatory documents as Frequency Not Known.

Officially documented adverse reactions are categorized primarily within two System Organ Classes (SOCs):

System Organ Class (SOC) Reported Adverse Reactions
Immune System Disorders Hypersensitivity reactions, including face oedema and dyspnoea (difficulty breathing).
Gastro-Intestinal Disorders Nausea and vomiting; other gastrointestinal changes have been reported.

Serious adverse events are rare and focus on severe hypersensitivity reactions (allergic responses). Specific safety constraints noted in regulatory labeling include a contraindication for individuals with known hypersensitivity to the drug or its excipients. Furthermore, the label notes that simultaneous administration may potentially reduce the absorption and efficacy of oral thyroid hormones, such as levothyroxine.

Regarding specific populations, no adverse effects are anticipated during pregnancy or lactation due to the compound's non-systemic action. However, certain liquid formulations may contain phenylalanine, which is a relevant consideration for patients with Phenylketonuria (PKU).

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Profile

The official regulatory profile for Espumisan, containing the active ingredient Simethicone, is characterized by its inertness and lack of systemic absorption. This profile is consistent across authoritative government sources, defining the substance as non-toxic when taken in excess.


Documented Overdose Information

Property Official Regulatory Statement
Documented Manifestations None documented. Systemic toxicity is not expected. Regulatory summaries often state that no cases of overdose with expected toxic effects have been reported.
Life-Threatening Outcomes None documented. Due to the physical mechanism of action, specific severe or systemic complications (e.g., cardiac or neurological effects) are not listed.
Antidote Availability No specific antidote. Treatment involves primarily discontinuing the medication.

Required Emergency Actions

Regulatory documentation emphasizes the need for a professional assessment following any accidental over-ingestion. This action is mandated as a general precaution for all medications, rather than for specific toxic effects of Simethicone.

  • Required Action: Contact a poison control center or emergency medical services at once following accidental over-ingestion.
  • Monitoring: Specific hospital monitoring or observation requirements are not typically mandated, reflecting the compound's non-absorbed nature.

This official structure defines the overdose situation by the absence of expected toxic effects, primarily requiring help-seeking for the event of over-ingestion itself.

Therapeutic Uses of Espumisan

What Espumisan Treats: Main Uses and Benefits

Simeticone, the active component in Espumisan, is commonly used for managing conditions presenting with systemic or localized discomfort related to gastrointestinal gas. The compound is applied in addressing symptom clusters that may become intense or disruptive and create noticeable functional strain, primarily for indications involving flatulence, bloating, abdominal fullness, and pressure. The therapeutic role of this agent focuses on these acute or episodic changes.


Quick Fact: Support for Symptoms related to heightened physiological activity.


The therapy provides support that helps ease the overall symptom burden during periods of heightened symptoms such as pressure and abdominal distension. Espumisan is generally utilized when short-term symptomatic assistance is needed, assisting with maintaining functional stability. This clinical context is relevant when supportive symptom management is appropriate.

“The treatment may assist with helping patients cope more steadily with symptom fluctuations.”

Regulatory References

  1. NIH StatPearls overview of Simethicone

Eligibility and Restrictions for Use

This section outlines the official population eligibility and exclusion criteria for Espumisan (Simethicone) based on governmental regulatory labeling.

Populations that Must Not Use Espumisan

Classification Exclusion Criteria (Contraindication)
Absolute Individuals with known hypersensitivity (allergy) to the active substance simethicone or to any specific excipients (e.g., Sunset Yellow FCF or E110).

Age-Based Eligibility

Eligibility is defined by the specific formulation used:

Formulation Approved Age Group (Regulatory Status)
Oral Drops / Emulsion Eligible for all age groups, including infants, children, adolescents, and adults.
Capsules (e.g., 40 mg) Eligible for children over 6 years of age, adolescents, and adults.

Pregnancy and Lactation Status

While the active substance, simethicone, is not systemically absorbed and is not expected to be excreted in breast milk, its use during both pregnancy and breastfeeding is generally not recommended in labeling due to the lack of dedicated human clinical data. Consultation with a healthcare provider is advised prior to use.

Eligibility Restrictions

Patients must consult a doctor if new or persistent gastrointestinal complaints occur while taking Espumisan, to rule out an underlying disease requiring alternative treatment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes the official regulatory information regarding interactions between Espumisan (Simethicone) and other substances.

Simethicone's interaction profile is governed by its unique non-systemic pharmacology, meaning it is not absorbed into the bloodstream and therefore does not participate in metabolic (e.g., CYP-enzyme) or systemic drug transporter interactions.


Documented Interaction Pattern

Field Official Regulatory Statement
Specific interacting medicines Levothyroxine (and related thyroid hormone preparations) is explicitly listed.
Mechanistic basis of interactions Physical absorption interference, a non-systemic mechanism.
Interaction-related restriction Co-administration must be managed to avoid the reduction in the bioavailability (systemic exposure) of the thyroid hormone preparation.
Timing-based interaction rules Separation of administration is required to mitigate the reduced absorption of the co-administered drug, as noted in official drug formularies.

Classification and Scope

Regulatory documents generally report that interactions with other medicines are not known, which is consistent with the drug’s physical mode of action.

No formal contraindicated combinations are documented in the interaction sections of major regulatory labels. Furthermore, no interactions with food, alcohol, or herbal products are officially specified as clinically relevant or requiring mandatory restriction. The interaction profile is limited exclusively to the risk of physical interference with the absorption of Levothyroxine within the gastrointestinal lumen.

Mechanism of Action

How Espumisan Works

The action of Espumisan is attributed to its active substance, simeticone, which operates via a purely physiochemical mechanism defined by its non-systemic nature. This means the action is confined entirely to the gastrointestinal lumen, without modulating biological targets like receptors or enzymes, and the substance is not absorbed into the bloodstream.

Targeting the Physical Surface Tension of Trapped Gas

Simeticone functions as an inert surfactant to engage the physical target—the surface tension of the numerous small gas bubbles trapped in the intestinal contents. By drastically reducing this surface tension, the mechanism acts to destabilize the stable foamy structure of the gas. This domain initiates the subsequent physiochemical cascade.

Initiating Mechanical Coalescence and Gas Clearance

The reduced surface tension causes the segregated gas pockets to rapidly coalesce (merge) into a bulk mass of free gas. This mechanical consolidation permits effective transport and clearance of the gas mass through natural peristaltic movements or absorption. The resulting physiological consequence of this facilitated clearance is the diminished physical volume and lowered intraluminal gas pressure.

Functional Limitation: Non-Inhibition of Gas Production

A key mechanistic scope limitation is that the drug does not engage or modulate the biological systems responsible for gas production (e.g., intestinal fermentation). The mechanism is solely applied to facilitate the clearance of gas once it has formed and become trapped in the foamy state, ensuring the action is limited to the mechanical lowering of localized pressure.

Dosage and Administration Information

How to Use Espumisan (Simethicone)

Administration and dosing for Espumisan are established for the oral route in dosage forms such as soft capsules or oral drops (emulsion).

Administration and Preparation

Dosage Form Preparation Requirement
Soft Capsules Swallow the capsule whole with water.
Oral Drops/Emulsion Shake the bottle well before use. Measure the required dose using a dropper or dosing pump.

Dosing Schedule and Timing

For symptomatic treatment, the dosage is typically taken 3 to 5 times daily. The medicine should be administered during or after meals, and an additional dose may be taken before bedtime if needed. The duration of treatment is permitted for an extended period, continuing until symptoms have fully disappeared.

Population-Specific Dosing (Simethicone)

Specific dosing regimens apply based on age group:

  • Infants (over 1 month): The typical daily dose is 40–80 mg, divided into 2 to 4 administrations. The drops may be mixed with milk in a bottle or given on a spoon.
  • Children (1–6 years): 40 mg per dose, 3 to 5 times daily.
  • Adults and Adolescents: 80 mg per dose, 3 to 5 times daily.

Special Procedural Use

For use as an aid in abdominal diagnostic procedures (e.g., ultrasound or X-ray), a fixed schedule is followed. This typically involves doses taken three times on the day preceding the examination and a final dose on the morning of the procedure, often on an empty stomach. For endoscopy, 160–320 mg may be administered prior to or during the examination.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Espumisan

Evidence for Symptomatic Relief of Gas-Related Discomfort

Research has been conducted on Simethicone (the active ingredient in Espumisan) in studies exploring symptom activity, such as bloating, fullness, and abdominal pressure. These investigations primarily involve Randomized Controlled Trials (RCTs) and systematic reviews, which applied in studies examining patient-reported experiences related to physical discomfort. Studies monitored outcomes related to systemic or functional imbalance experienced by patients.

Certainty remains low in some areas. Findings were mixed or inconsistent when research examined more complex functional disorders. Furthermore, many investigations used the compound in combination products with other agents, meaning the specific contribution of Simethicone alone to the observed patterns is uncertain. Follow-up durations were limited in many studies, and there is limited information for long-term outcomes related to this use.


Evidence for Use as a Diagnostic Aid

Simethicone was studied for a completely separate application: its use as an aid in diagnostic procedures. These studies focus on eliminating gas bubbles to improve the clarity of internal structures during examinations like endoscopy (examining the upper digestive tract) and colonoscopy. The research structure for this application has been assigned a High evidence level classification, predominantly consisting of meta-analyses of RCTs.

The research examined outcomes related to visualization quality and the absence of obscuring foam in the gut. Data show patterns related to an association between the use of Simethicone before the procedure and changes in the clarity of the examined area. Research provides insight into the compound's characteristics as described in study reports. The research describes consistency in reporting for this diagnostic use.


Studies on Specific Patient Groups

Research has explored a few specific patient groups where symptoms may vary in intensity, notably the application for infantile colic. Here, the evidence quality varies across studies, and the findings were mixed. Evidence is limited for this group; several systematic reviews reported findings where studies did not report a measurable difference in outcomes compared to a placebo. Consequently, the certainty remains low regarding the patterns observed in this specific population. Results apply only to the populations studied, and there is limited data for other special populations.

Key Studies & References

  1. Simethicone: A Review of its Use in Diagnostic and Therapeutic Settings

Frequently Asked Questions (FAQ)

Common questions about Espumisan (FAQ)

Q: Can Espumisan be taken long-term for chronic gas problems?

A: Simethicone, the active ingredient, is considered well-tolerated because it is not absorbed into the body. Official regulatory directions permit using the medicine for an extended period until gas-related symptoms have fully resolved. If symptoms persist or worsen, consulting a healthcare professional is advised.

Q: What are the most commonly reported minor side effects of Espumisan?

A: Simethicone has a limited adverse event profile due to its purely physical action within the gut. Since frequency is 'not known,' regulatory documents report adverse events that may involve gastrointestinal changes. These reported changes include instances of nausea, vomiting, constipation, or loose stools.

Q: Is Espumisan effective for gas caused by specific foods like beans or broccoli?

A: Espumisan’s action is to physically collapse the foamy gas bubbles trapped in the digestive system. While it facilitates the clearance of gas once it is formed, regulatory information confirms that it does not prevent or modulate the biological systems responsible for gas production, such as the fermentation caused by certain foods.

Q: Are there any special dietary recommendations while taking Espumisan?

A: Official regulatory documents and safety data for the product state that no interactions with food, alcohol, or herbal products are officially specified as clinically relevant. This means there are generally no mandatory dietary restrictions while taking this medicine.

Q: Can people with diabetes safely take Espumisan?

A: The active ingredient, simethicone, is not systemically absorbed. However, official safety information notes that certain liquid formulations may contain ingredients like phenylalanine (relevant for PKU). Patients with diabetes may need to check the excipient (non-active ingredient) list for sugars in flavored formulations, or consult their doctor.

Q: Can Espumisan interact with herbal remedies like peppermint oil?

A: Regulatory documents state that interactions with other medicines, including herbal products, are generally not known because simethicone is not absorbed into the bloodstream. For any concerns about combining medicines or supplements, consulting a healthcare professional is recommended.

Q: What is the role of Espumisan in relieving post-operative bloating?

A: Official sources confirm that simethicone is indicated for the symptomatic treatment of conditions such as post-operative gas pains and gaseous distension. Its mechanism, which clears trapped gas, is consistent with its regulatory indication for postoperative gas pain and distension.

Q: Is Espumisan considered safe for the elderly population?

A: Official regulatory information does not indicate that individuals in the elderly population experience different side effects or problems when taking simethicone. No specific restrictions or different side effects have been reported in the elderly population compared to other adult age groups, according to official information.

Q: How long do the effects of Espumisan typically last after a single dose?

A: The common dosing schedule, which involves taking the product multiple times daily (e.g., after each meal and at bedtime), suggests the duration of relief is shorter than 24 hours. This aligns with an expected duration of relief that lasts for several hours per dose.

Q: Is it normal to feel a change in bowel habits after taking Espumisan?

A: Changes in gastrointestinal function are reported as possible, though rare, adverse events. Regulatory safety documents include both constipation and loose stools among the listed gastrointestinal changes. If persistent constipation or other changes occur, a healthcare provider should be consulted.

Q: What happens if you accidentally take more Espumisan than recommended?

A: Due to its non-systemic nature, the risk of poisoning is low. However, official safety labeling includes a standard warning that immediate medical assistance or contact with a poison control center is advised in the event of an accidental overdose.

Q: Can Espumisan cause or worsen constipation in some individuals?

A: Yes, constipation is listed in official regulatory documents among the reported gastrointestinal adverse events, though its frequency is generally rare or 'not known.' If persistent constipation or other changes occur, a healthcare provider should be consulted.

Q: Does Espumisan lose its potency if it's stored improperly?

A: Yes, regulatory labeling requires storing the medicine below specified temperatures and protecting it from light, heat, and moisture. These mandated conditions are necessary to maintain the drug's stability and ensure its full potency is preserved until the expiry date.

Q: Does taking Espumisan mask symptoms of a more serious condition?

A: Yes, this is an important safety consideration. Official regulatory texts advise consulting a doctor if gastrointestinal complaints are new, persist, or worsen while taking the medicine. This is to ensure an underlying disease that requires alternative or immediate treatment is ruled out.

Q: Is there a non-oral form of Espumisan for gas relief?

A: No, the dosage forms approved in regulatory documents are exclusively for oral administration. These include soft capsules, oral drops (emulsion), and chewable tablets.

Q: Can Espumisan be taken with antacids at the same time?

A: Simethicone has a minimal risk of systemic interaction due to its non-absorption. While official labels do not always explicitly list antacids, they have no reported systemic interactions with simethicone. Consulting a healthcare provider is generally recommended for any concerns regarding co-administration.

Q: Can Espumisan help with burping or only lower intestinal gas?

A: The medicine is indicated for symptomatic relief across the entire digestive tract. This includes upper gastrointestinal symptoms such as bloating, pressure, and fullness, which can be associated with burping and upper GI gas.

Q: Is it necessary to drink a full glass of water when taking Espumisan capsules?

A: Official administration instructions require that the capsule be swallowed 'whole with water.' The instructions do not specify a volume beyond 'with water,' indicating that enough water to swallow the capsule comfortably is typically sufficient.

Q: Can Espumisan be taken on an empty stomach?

A: Typical dosing instructions recommend taking the medicine during or after meals and at bedtime. However, regulatory texts also confirm that for use prior to diagnostic procedures (like an ultrasound), a dose is often taken on the morning of the procedure, which may be on an empty stomach.

Q: Can Espumisan be used for trapped wind pain in the chest area?

A: The medicine is indicated for the symptomatic relief of gas-related complaints like bloating, fullness, and pressure. The medicine is indicated for symptomatic relief of bloating and pressure, which can occur in the upper abdomen and chest area.

Q: Does Espumisan affect the results of blood tests?

A: Simethicone is reported in some safety literature to interfere with specific stool tests, such as causing false-negative results in the gastric guaiac test. However, there are generally no specific warnings in regulatory documents regarding interference with common blood tests.

Q: Does Espumisan have a noticeable taste or odor?

A: While the capsules are generally neutral, certain liquid and chewable formulations list flavor as an inactive ingredient in regulatory documents. This indicates that these specific formulations are designed to have a taste or odor.

Q: What should I do if I forget to take a dose of Espumisan?

A: If a dose is missed, the general guidance for this type of medication is to skip the missed dose if the next scheduled dose is approaching. It is advised to continue with the regular dosing schedule and avoid taking two doses at the same time.

How should Espumisan be stored and disposed of?

Storage and Disposal of Espumisan (Simeticone)

Storage Requirements

Official labeling instructs that Espumisan should be stored at room temperature, typically specified as below 25°C or 30°C. The medicine must be stored where children cannot see or reach it, serving as a mandatory child-safety measure. The product container should be kept tightly closed and protected from light, heat, and moisture. It is important not to refrigerate or freeze the liquid oral drops, as this may compromise stability.

Stability and Disposal

The medicine must not be used after the expiry date (EXP) printed on the packaging. For the oral drops, the official in-use shelf life is 6 months after the bottle is first opened, after which the product must be discarded. Regarding disposal, unused or expired Espumisan must not be thrown away with household waste or down the sink. Patients should consult their pharmacist for instructions on proper pharmaceutical waste disposal to protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Espumisan found in:

A-Z Index: